Bon Natural Life Ltd. (Nasdaq: BON), a leading bio-ingredient solution provider in the natural, health, and personal care industry based in Xi'an, China, has announced that it has regained compliance with Nasdaq's continued listing requirements. The company received official confirmation from the Nasdaq Hearings Panel on July 2, 2025, indicating that it successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2). Consequently, BON's request to maintain its listing on the Nasdaq Capital Market has been approved. The company had submitted a compliance plan on May 16, 2025, and presented its case on June 5, 2025. BON will remain under a Discretionary Panel Monitor for one year to ensure ongoing compliance with Nasdaq's listing standards.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。